Dec. 5, 2016 -- LUGPA, a trade association that advocates for independent urology group practices, today announced its collaboration with Integra Connect to develop advanced alternative payment models (APMs). During the transition from a fee-for-service reimbursement model to one of value-based care brought about by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), LUGPA is dedicated to providing leadership to assist independent urology practices with the development and validation of urology-specific APMs.
Since no eligible APM options for urology currently exist, the Centers for Medicare and Medicaid Services (CMS) recognized the need for specialty-specific APMs and created a process by which stakeholders, like LUGPA, can develop and submit specific APM models for CMS review and approval. For an independent urology practice to benefit from an APM, providers need integrated clinical and financial systems that can monitor not only treatment pathway adherence and quality metrics, but also patient outcomes and practice costs.
After an extensive search, LUGPA selected Integra Connect as its partner to develop urology-specific APMs, based on Integra Connect's deep experience with population health management and payer initiatives which will assist LUGPA with the MACRA transition to value-based care.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new
treatments, enrolling clinical trials, screening and surveillance
recommendations along with updated guidelines. Join us as one of our
subscribers who rely on UroToday as their must-read source for the
latest news and data on drugs. Sign up today for blogs, video
conversations, conference highlights and abstracts from peer-review
publications by disease and condition delivered to your inbox and read
on the go.
Initially, LUGPA will develop two APM projects with LUGPA practice involvement:
LUGPA has currently grown to represent more than 25 percent of the nation's urology practices, comprising more than 2,100 members, who account for approximately 30 percent of urologic care in the United States. The Association is committed to providing the best resources and information for its member practices through advocacy, research, data collection and benchmarking efforts. LUGPA advocates for independent urology practices by promoting quality clinical outcomes, fostering new opportunities and improving advocacy in the legislative and regulatory arenas.
- Prostate Cancer Biopsy Taking Risk on Sepsis; and
- Positive Biopsy/Localized Prostate Cancer.